Unihealth Hospitals Ltd

Unihealth Hosp Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Unihealth Hospitals Ltd

₹ 167 0.30%
12 Sep - close price
Company website NSE - SME: UNIHEALTH
About

Incorporated in 2010, Unihealth Consultancy Ltd is in the business of Medical Tour Operator and Health Consultancy Service & Trader in Medical Equipments[1]

Key Points

Business Overview:[1]
Headquartered in Mumbai, Unihealth Hospitals Ltd is a diversified healthcare service provider with a global presence, particularly in Africa. The company operates under the 'UMC Hospitals' brand and provides:
- Hospital and medical centre services,
- Healthcare consultancy and project management,
- Export and distribution of pharmaceutical and medical consumables,
- Medical value travel facilitation for international patients.

Website NSE - SM
  • Market Cap ₹ 257 Cr.
  • Current Price ₹ 167
  • High / Low ₹ 191 / 120
  • Stock P/E 110
  • Book Value ₹
  • Dividend Yield 0.00 %
  • ROCE 4.72 %
  • ROE 3.55 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Company is almost debt free.

Cons

  • Company has a low return on equity of 5.90% over last 3 years.
  • Earnings include an other income of Rs.3.31 Cr.
  • Company has high debtors of 298 days.
  • Working capital days have increased from 267 days to 412 days

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Healthcare Healthcare Healthcare Services Hospital

Edit Columns
Loading peers table ...

Half Yearly Results

Standalone Figures in Rs. Crores / View Consolidated

Sep 2023 Mar 2024 Sep 2024 Mar 2025
0.92 3.31 1.56 2.00
1.23 1.04 1.38 1.97
Operating Profit -0.31 2.27 0.18 0.03
OPM % -33.70% 68.58% 11.54% 1.50%
0.96 1.37 1.50 1.80
Interest 0.32 0.02 0.00 0.02
Depreciation 0.04 0.12 0.13 0.15
Profit before tax 0.29 3.50 1.55 1.66
Tax % -72.41% 27.43% 27.10% 27.71%
0.50 2.54 1.13 1.21
EPS in Rs
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
0.63 1.61 1.92 4.23 3.56
0.94 0.79 1.36 2.28 3.35
Operating Profit -0.31 0.82 0.56 1.95 0.21
OPM % -49.21% 50.93% 29.17% 46.10% 5.90%
0.06 0.94 1.79 2.33 3.31
Interest 0.80 1.19 1.15 0.34 0.03
Depreciation 0.11 0.09 0.08 0.16 0.28
Profit before tax -1.16 0.48 1.12 3.78 3.21
Tax % 0.00% 0.00% -19.64% 19.84% 27.41%
-1.16 0.48 1.34 3.04 2.33
EPS in Rs
Dividend Payout % 0.00% 0.00% 0.00% 0.00% 0.00%
Compounded Sales Growth
10 Years: %
5 Years: %
3 Years: 30%
TTM: -16%
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: 69%
TTM: -23%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: %
1 Year: 8%
Return on Equity
10 Years: %
5 Years: %
3 Years: 6%
Last Year: 4%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Equity Capital 1.34 1.34 1.39 15.40 15.40
Reserves 4.69 5.17 11.28 49.07 51.41
6.96 11.60 12.08 3.30 2.66
3.67 0.42 0.61 0.71 0.95
Total Liabilities 16.66 18.53 25.36 68.48 70.42
1.60 1.50 1.42 3.09 3.15
CWIP 0.00 0.00 0.00 0.00 0.00
Investments 6.15 6.15 6.34 18.37 30.50
8.91 10.88 17.60 47.02 36.77
Total Assets 16.66 18.53 25.36 68.48 70.42

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
-0.32 2.25 1.97 -2.46 0.57
0.06 -6.13 -7.17 -10.50 -21.93
0.19 3.93 5.09 39.57 -1.13
Net Cash Flow -0.07 0.05 -0.11 26.61 -22.48

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Debtor Days 857.46 476.09 117.86 225.21 298.36
Inventory Days 0.00
Days Payable
Cash Conversion Cycle 857.46 476.09 117.86 225.21 298.36
Working Capital Days 4,745.00 562.24 26.61 361.55 412.16
ROCE % 10.74% 10.59% 8.91% 4.72%

Shareholding Pattern

Numbers in percentages

Sep 2023Mar 2024Sep 2024Mar 2025
68.80% 68.80% 68.93% 68.93%
5.61% 0.00% 0.00% 0.00%
3.31% 0.14% 0.02% 0.23%
22.27% 31.05% 31.05% 30.83%
No. of Shareholders 1,111979984985

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

Credit ratings

Concalls